No standalone federal psychedelic scheduling bill will pass both chambers before the 2026 midterms.

Right now, Congress has no psychedelic scheduling bills scheduled for a real hearing. The DEA (Drug Enforcement Administration) opposes them. With fewer than 15 weeks of actual legislative time left before the November 2026 elections, a standalone bill has almost no chance—the only realistic path would be sneaking it into a larger military spending bill or budget bill.

Standalone psychedelic scheduling bills have no committee hearing scheduled, face DEA opposition, and the congressional calendar leaves fewer than 15 legislative weeks before November 2026. NDAA or appropriations riders remain the only plausible vehicles. The duplicate prediction (#3) is removed; this higher-confidence, better-sourced version is retained.